Supreme Court Hears Landmark MedImmune Appeal
The U.S. Supreme Court heard oral arguments Wednesday in the patent-license dispute between biotechnology rivals MedImmune Inc. and Genentech Inc., in a case that will determine just how stable relationships between...To view the full article, register now.
Already a subscriber? Click here to view full article